These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Don't miss a chance taking the best shot!! Kiuchi K J Cardiovasc Electrophysiol; 2020 Nov; 31(11):3069-3070. PubMed ID: 32991005 [No Abstract] [Full Text] [Related]
45. Necrosis avidity: a newly discovered feature of hypericin and its preclinical applications in necrosis imaging. Jiang B; Wang J; Ni Y; Chen F Theranostics; 2013; 3(9):667-76. PubMed ID: 24052807 [TBL] [Abstract][Full Text] [Related]
46. Current oncologic applications of radiofrequency ablation therapies. Shah DR; Green S; Elliot A; McGahan JP; Khatri VP World J Gastrointest Oncol; 2013 Apr; 5(4):71-80. PubMed ID: 23671734 [TBL] [Abstract][Full Text] [Related]
47. Magnetic resonance imaging after radiofrequency ablation in a rodent model of liver tumor: tissue characterization using a novel necrosis-avid contrast agent. Ni Y; Chen F; Mulier S; Sun X; Yu J; Landuyt W; Marchal G; Verbruggen A Eur Radiol; 2006 May; 16(5):1031-40. PubMed ID: 16429271 [TBL] [Abstract][Full Text] [Related]
48. VX2 carcinoma in rabbits after radiofrequency ablation: comparison of MR contrast agents for help in differentiating benign periablational enhancement from residual tumor. Kim TJ; Moon WK; Cha JH; Goo JM; Lee KH; Kim KH; Lee JW; Han JG; Weinmann HJ; Chang KH Radiology; 2005 Feb; 234(2):423-30. PubMed ID: 15591437 [TBL] [Abstract][Full Text] [Related]
49. Science to practice: can we differentiate residual untreated tumor from tissue responses to heat following thermal tumor ablation? Goldberg SN Radiology; 2005 Feb; 234(2):317-8. PubMed ID: 15670988 [No Abstract] [Full Text] [Related]
50. Dynamic contrast-enhanced MR imaging of VX2 carcinomas after X-irradiation in rabbits: comparison of gadopentetate dimeglumine and a macromolecular contrast agent. Kim YH; Choi BI; Cho WH; Lim S; Moon WK; Han JK; Weinmann HJ; Chang KH Invest Radiol; 2003 Sep; 38(9):539-49. PubMed ID: 12960523 [TBL] [Abstract][Full Text] [Related]
51. Magnetic resonance imaging for hepatic radiofrequency ablation. Clasen S; Boss A; Schmidt D; Fritz J; Schraml C; Claussen CD; Pereira PL Eur J Radiol; 2006 Aug; 59(2):140-8. PubMed ID: 16716553 [TBL] [Abstract][Full Text] [Related]
52. Differentiation of residual tumor from benign periablational tissues after radiofrequency ablation: the role of MR imaging contrast agents. Ni Y; Chen F; Marchal G Radiology; 2005 Nov; 237(2):745-7; author reply 748-9. PubMed ID: 16244283 [No Abstract] [Full Text] [Related]